中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

75 records (took 0.03 seconds)

    Reduction in damage to optical elements used in optical lithography for device fabrication
    41.
    发明授权
    Reduction in damage to optical elements used in optical lithography for device fabrication 失效
    减少光学元件用于器件制造的光学元件的损坏

    公开(公告)号：US5891605A

    公开(公告)日：1999-04-06

    申请号：US586412

    申请日：1996-01-16

    Applicant: Stuart Thomas Stanton

    Inventor： Stuart Thomas Stanton

    IPC: G03F7/20 ,  H01L21/027 ,  G03C5/00

    CPC classification number: G03F7/70583 ,  G03F7/70241

    Abstract: An optical lithographic process and system for fabricating devices which includes an optical subsystem for reducing the rate of damage to the system's optics caused by exposure to energy pulses from an exposure source. The optical subsystem transforms a primary energy pulse from the exposure source into N secondary pulses, where N is .gtoreq.2 with a delay provided between each secondary pulse so as to reduce the peak intensity of the energy pulse being transmitted through the optical system. The subsystem redirects the secondary pulses spatially to satisfy source requirements for appropriate lithographic illuminators. Furthermore, the subsystem may be an intrinsic design feature of the illuminator or exposure source.

    Abstract translation: 一种用于制造器件的光学光刻工艺和系统，其包括用于降低由暴露于来自曝光源的能量脉冲引起的对系统光学器件的损伤率的光学子系统。 光学子系统将来自曝光源的一次能量脉冲变换为N次次脉冲，其中N在每个次级脉冲之间具有延迟，其中N是> / = 2，以便减少通过光学系统传输的能量脉冲的峰值强度。 子系统在空间上重新定向二次脉冲，以满足适当光刻照明器的光源要求。 此外，子系统可以是照明器或曝光源的固有设计特征。

    System, method, and program product for unit transfer fee processing
    46.
    发明授权
    System, method, and program product for unit transfer fee processing 有权
    单位转让费处理的系统，方法和程序产品

    公开(公告)号：US08538839B2

    公开(公告)日：2013-09-17

    申请号：US13311268

    申请日：2011-12-05

    Applicant: Paul Edward Kuhnle ,  George Tedesche Simon ,  John Stuart Thomas ,  Mark Steven Criscitello ,  Daniel Joseph McCabe

    Inventor： Paul Edward Kuhnle ,  George Tedesche Simon ,  John Stuart Thomas ,  Mark Steven Criscitello ,  Daniel Joseph McCabe

    IPC: G07B17/00

    CPC classification number: G06Q40/04

    Abstract: A method, system and program product, the method comprising: accessing Transfer Fee data to be paid to a third party that is not the borrower or the lender of a security for a right to loan one or more units of the security; accessing loan data on a loan of units of the security, calculating an amount of a Transfer Fee for the right to loan the security; generating data for debiting an account or sending a bill for the Transfer Fee; sending or having sent data on revenue from one or more of the Transfer Fees to be paid to an issuer of the security; updating the database with data on the Transfer Fee.

    Abstract translation: 一种方法，系统和程序产品，所述方法包括：访问要支付给不是借款人的第三方的转移费用数据或贷款一个或多个安全单位的权利的担保人的贷款人; 获得贷款单位的贷款数据，计算贷款担保权的转移费用金额; 生成用于借记帐户或发送转帐费用的帐单的数据; 发送或已经将一笔或多笔转让费用的数据发送给安全发行人; 使用转移费用数据更新数据库。

    Exchange traded funds and mutual funds providing cash flow distributions
    49.
    发明授权
    Exchange traded funds and mutual funds providing cash flow distributions 失效
    交易所交易基金和共同基金提供现金流量分配

    公开(公告)号：US07983981B1

    公开(公告)日：2011-07-19

    申请号：US12337618

    申请日：2008-12-17

    Applicant: Daniel Joseph McCabe ,  John Stuart Thomas ,  Mark Steven Criscitello ,  Paul Edward Kuhnle ,  George Tedesche Simon

    Inventor： Daniel Joseph McCabe ,  John Stuart Thomas ,  Mark Steven Criscitello ,  Paul Edward Kuhnle ,  George Tedesche Simon

    IPC: G06Q40/00

    CPC classification number: G06Q40/06 ,  G06Q40/00 ,  G06Q40/04

    Abstract: A collective investment vehicle that provides cash distributions. The distributions provide a cash flow to holders of the collective investment vehicle securities, and also allow the value of the collective investment vehicle securities to be reset to a target level. The distributions may be scheduled to occur periodically, or may be based on the occurrence of specific events including company events, economic events, political events, etc. In some embodiments, the funds required for cash distributions are obtained without incurring any capital gains, and the distributions may be treated as a return of capital.

    Abstract translation: 提供现金分配的集体投资工具。 这些分配向集体投资车辆证券持有人提供现金流量，并将集体投资车辆证券的价值重置为目标水平。 分配可以计划定期发生，或者可以基于特定事件的发生，包括公司事件，经济事件，政治事件等。在一些实施例中，获得现金分配所需的资金而不产生任何资本收益，并且 分配可以被视为资本回报。

    IKK-BETA SERINE-THREONINE PROTEIN KINASE INHIBITORS
    50.
    发明申请
    IKK-BETA SERINE-THREONINE PROTEIN KINASE INHIBITORS 失效
    IKK-BETA丝氨酸蛋白激酶激酶抑制剂

    公开(公告)号：US20100087515A1

    公开(公告)日：2010-04-08

    申请号：US12513206

    申请日：2007-10-29

    Applicant: David Festus Charles Moffat ,  Stephen John Davies ,  Michael Hugh Charlton ,  Simon Christopher Hirst ,  Stuart Thomas Onions ,  Jonathan Gareth Williams

    Inventor： David Festus Charles Moffat ,  Stephen John Davies ,  Michael Hugh Charlton ,  Simon Christopher Hirst ,  Stuart Thomas Onions ,  Jonathan Gareth Williams

    IPC: A61K31/381 ,  C07D333/38 ,  C12N9/99 ,  A61P35/00 ,  A61P37/00 ,  A61P29/00 ,  A61P1/00 ,  A61P11/00

    CPC classification number: C07D333/38

    Abstract: Compounds of formula (IA) or (IB) are inhibitors of IkB kinase (IKK) activity, and are useful in the treatment of autoimmune and inflammatory diseases: Formula (A) and (B) wherein R7 is hydrogen or optionally substituted (C1-C6)alkyl; ring A is an optionally substituted aryl or heteroaryl ring of 5-13 ring atoms; Z is (a) a radical of formula R1R2CHNH—Y-L1-X1—(CH2)z— wherein: z is 0 or 1; R1 is a carboxylic acid group (—COOH), or an ester group which is hydrolysable by one or more intracellular esterase enzymes to a carboxylic acid group; R2 is the side chain of a natural or non-natural alpha amino acid; Y is a bond, —C(═O)—, —S(═P)2-, —C(═O)O—, —C(═O)NR3-, —C(═S)—NR3, —C(═NH)—NR3 or —S(═O)2NR3— wherein R3 is hydrogen or optionally substituted C1-C6 alkyl; L is a divalent linker radical of formula -(Alk1)m(Q)(Alk2)p- wherein m, n, p, Q, AIk1 and AIk2 are as defined in the claims.

    Abstract translation: 式（IA）或（IB）的化合物是IkB激酶（IKK）活性的抑制剂，可用于治疗自身免疫性和炎性疾病：式（A）和（B）其中R 7为氢或任选取代的（C1- C6）烷基; 环A是任选取代的5-13个环原子的芳基或杂芳基环; Z是（a）式R1R2CHNH-Y-L1-X1-（CH2）z-的基团，其中：z为0或1; R 1是羧酸基团（-COOH）或可被一个或多个细胞内酯酶水解成羧酸基团的酯基; R2是天然或非天然α氨基酸的侧链; Y是键，-C（= O） - ， - S（= O）2 - ， - C（= O）O-，-C（= O）NR 3 - ， - C（= NH）-NR 3或-S（= O）2 NR 3 - ，其中R 3是氢或任选取代的C 1 -C 6烷基; L1是式 - （Alk1）m（Q）（Alk2）p的二价连接基团，其中m，n，p，Q，Alk1和Alk2如权利要求中所定义。

Patent Agency Ranking